サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：生物製剤アウトソーシング市場：製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1290847

生物製剤アウトソーシング市場：製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Biologics Outsourcing Market with COVID-19 Impact Analysis, By Product Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日
ページ情報
英文 379 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
生物製剤アウトソーシング市場：製品タイプ別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年06月01日
発行: AnalystView Market Insights
ページ情報: 英文 379 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

生物製剤アウトソーシング市場規模は2022年に804億1,030万米ドルとなり、2023年から2030年にかけてCAGR 18.7%で拡大

生物製剤アウトソーシング市場- 市場力学

先進生物製剤の開発・製造能力を経済的に利用するため、バイオ医薬品企業の間でアウトソーシングの傾向が強まっており、市場の成長を促進すると予想されます。

バイオ医薬品業界におけるアウトソーシングの増加傾向は、企業がコスト効率の高い方法で高度な生物製剤の開発・製造能力を利用することを可能にします。アウトソーシングにより、企業は多額の設備投資をすることなく、高度な施設、設備、専門知識を利用することができます。CRO（医薬品開発業務受託機関）やCMO（医薬品製造業務受託機関）には、複雑な生物製剤プロセスを処理するために必要なスキルを有する経験豊富な科学者や技術者が揃っています。2023年現在、米国には2,823の調査受託機関があり、2022年から0.9％増加しています。米国の業界統計によると、売上高に占めるCRO業界の事業コストの割合は、賃金（29.1％）、購買（6.8％）、家賃・光熱費（3.4％）です。アウトソーシング・パートナーの専門知識とインフラを活用することで、企業は業務を最適化し、財務リスクを低減し、生物製剤の商業化を加速することができます。

生物製剤アウトソーシング市場-主な洞察

  • 生物製剤アウトソーシング産業は、持続可能な成長に対する意識の高まりにより、著しい成長を遂げると予測される
  • 製品タイプ別では、2022年には抗体が主要タイプに
  • 用途別では、2022年には治療薬が主要タイプとなっています。
  • 地域別では、北米が2022年の売上高をリードしています。

生物製剤アウトソーシング市場-セグメンテーション分析：

世界の生物製剤アウトソーシング市場は、特異性、タイプ、用途、地域に基づいて区分されます。

市場は製品タイプに基づいて5つのカテゴリーに分けられる：抗体、遺伝子組み換え、タンパク質、ワクチン、その他。市場が支配的なのは抗体です。これらは一般的に外注されるタイプの生物学的製剤です。抗体は、病原体や異常細胞などの異物の存在に反応して免疫系が産生するタンパク質です。抗体の開発・製造をアウトソーシングすることで、バイオ医薬品企業にはいくつかのメリットがもたらされます。

市場は用途によって3つのカテゴリーに分けられる：治療薬、診断薬、調査です。治療薬が市場を独占しており、予測期間中もその優位性は維持されるであろう。生物製剤のアウトソースは治療目的で使用され、多くの場合、がん、自己免疫疾患、遺伝性疾患などの複雑な疾患の治療に使用されます。生物製剤アウトソーシング市場とは、生物製剤や治療薬の開発、製造、商業化に関連するさまざまなプロセスのアウトソーシングを指します。

生物製剤アウトソーシング市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに区分されます。生物製剤アウトソーシング市場は、バイオ製薬企業の研究開発費の増加、バイオシミラー医薬品の承認と普及の拡大により、北米が圧倒的なシェアを占めると予想されます。北米のバイオ医薬品企業は、研究開発活動に多大なリソースを割いています。研究開発に注力することで、革新的な生物学的製剤や治療法の開発が可能になります。米国研究製薬工業協会（Pharmaceutical Research and Manufacturers of America）の予測では、米国のバイオ医薬品業界は新薬開発において世界をリードしており、PhRMA会員企業はその最前線に立ち続けています。米国バイオ医薬品全体の2020年の研究開発投資額は1,220億米ドルと推定されます。欧州とアジア太平洋は、細胞株工学（遺伝子編集ツール）と細胞株開発技術の技術的進歩により、生物製剤アウトソーシング市場の大幅な成長を促進すると予想されます。

生物製剤アウトソーシング市場-競合情勢：

企業は、細胞株開発技術を強化し、新製品を開発し、新規治療用途を探索するために、研究開発に多額の投資を行っています。生物製剤アウトソーシング市場は競争が激しく、複数の企業が市場シェアを争っています。例えば、2023年にはベーリンガーインゲルハイムが3億8,600万米ドルのドイツ研究開発工場を開設します。この生物製剤開発センター（BDC）では、抗体や治療用タンパク質の開発、臨床試験用物質の製造が行われるとベーリンガーインゲルハイムは述べています。バイオシミラーの成長とその開発・製造の必要性も、生物製剤のアウトソーシング需要に寄与しています。バイオシミラー開発企業は、その専門知識とインフラを活用するため、しばしばアウトソーシング・パートナーを頼りにしています。

最近の動き

2022年4月、バイオ医薬品、細胞、遺伝子、および消費者向け医療のパートナーが、複数のモダリティにまたがるより優れた患者向け治療の開発、上市、および供給を最適化できるようにする世界・リーダーであるキャタレント社は、現在英国オックスフォード近郊に建設中の生物製剤の開発・製造施設をワクチン・マニュファクチャリング・アンド・イノベーション・センター・UKリミテッド（VMIC Ltd.）から買収したことを発表しました。

研究の主な特徴

  • この生物製剤アウトソーシング市場に関する調査レポートは、2022年を基準年として、市場規模、年間平均成長率（CAGR %）、推定・予測（2023-2030年）を提供しています。
  • この調査レポートは、生物製剤のアウトソーシング市場に関する最新動向の洞察を顧客に提供します。
  • 調査レポートは、異なるセグメント/国にわたる潜在的な成長機会を解明し、生物製剤アウトソーシング市場の魅力的な投資提案マトリクスを説明します。
  • 全体的なレポートでは、新規投資機会、既存企業が直面する課題、生物製剤アウトソーシング市場で持続するための成長要因を特定しています。
  • COVID-19が生物製剤アウトソーシング市場規模、予測、CAGR、市場力学に与える影響について調査範囲で詳細に考察COVID後の生物製剤アウトソーシング市場に関する詳細な洞察もカバーします。
  • 本レポートのユーザーに生物製剤アウトソーシング市場の包括的な見解を提供するために、生物製剤アウトソーシング市場の競合情勢と主要イノベーター分析も含めています。
  • 本調査では、市場規模、成長率、魅力度に基づいてすべての業界セグメントをベンチマークとする成長見通しマッピング分析を網羅しています。
  • 主要市場参入企業の詳細な企業プロファイルを掲載しており、生物製剤アウトソーシング市場で事業展開する企業の財務情報や戦略的イニシアチブを理解するのに役立ちます。
  • さらに、本レポートでは、世界レベルだけでなく、地域レベルで市場に関与する主要参入企業の重要な買収＆合併、提携＆ジョイントベンチャー、新発売、研究開発、地域展開も明らかにしています。
  • 生物製剤アウトソーシングの世界市場レポートは主に、サプライヤー、投資家、新規参入者、流通業者、金融アナリストなど、この業界の様々な利害関係者を対象としています。

目次

第1章 生物製剤アウトソーシング市場概要

  • 調査範囲

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 生物製剤アウトソーシングの主要な市場動向

  • 生物製剤アウトソーシング市場促進要因
  • 生物製剤アウトソーシング市場抑制要因
  • 生物製剤アウトソーシング市場機会
  • 生物製剤アウトソーシング市場の今後の動向

第4章 生物製剤アウトソーシング産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 生物製剤アウトソーシング市場：COVID-19の影響分析

  • 新型コロナウイルス感染症以前の影響分析
  • 新型コロナウイルス感染症後の影響分析

第6章 生物製剤アウトソーシング市場情勢

  • 生物製剤アウトソーシング市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 確立された企業の分析
    • 新興企業の分析

第7章 生物製剤アウトソーシング市場- 製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • 抗体
    • 組換え
    • タンパク質
    • ワクチン
    • その他

第8章 生物製剤アウトソーシング市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 治療
    • 診断
    • 研究

第9章 生物製剤アウトソーシング市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • 主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • 主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- 生物製剤アウトソーシング業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Boehringer Ingelheim
    • Catalent
    • GenScript
    • Innovent Biologics
    • Syngene
    • Shanghai Medicilon
    • GL Biochem Corporation
    • GVK Biosciences Private
    • Horizon Discovery Group
    • Selexis
    • Lonza
    • Abzena
    • Adimab

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Biologics Outsourcing Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Biologics Outsourcing Market, by Product Type 2018-2030 (USD Million)
  • TABLE Biologics Outsourcing Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Biologics Outsourcing Market, by Application 2018-2030 (USD Million)
  • TABLE Biologics Outsourcing Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Biologics Outsourcing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biologics Outsourcing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biologics Outsourcing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Biologics Outsourcing Market, by Application, 2018-2030 (USD Million)
目次
Product Code: ANV1293

REPORT HIGHLIGHT

The Biologics Outsourcing Market size was valued at USD 80,410.3 million in 2022, expanding at a CAGR of 18.7% from 2023 to 2030.

Biologics are a more complex class of medicines to manufacture, package, store, and distribute than their chemical counterparts. Outsourcing of any aspect of the supply chain means pharmaceutical companies and their chosen vendors need to work in true partnership, navigating the complex process together to ensure speed to market. Developing and manufacturing biologic drugs in-house can be costly due to the need for specialized facilities, equipment, and personnel. Outsourcing allows companies to avoid or reduce these capital investments and instead pay for specific services or processes as needed, potentially resulting in cost savings.

Biologics Outsourcing Market- Market Dynamics

Increasing trend of outsourcing among biopharma companies to gain economical access to advanced biologics development and manufacturing capacities is expected to propel market growth

The increasing trend of outsourcing in the biopharmaceutical industry enables companies to gain access to advanced biologics development and manufacturing capacities in a cost-effective manner. Outsourcing allows companies to access advanced facilities, equipment, and expertise without the need for substantial capital investments. contract research organizations (CROs)and contract manufacturing organizations (CMOs) are equipped with experienced scientists and technicians who possess the necessary skills to handle complex biologics processes. There are 2,823 Contract Research Organizations businesses in the US as of 2023, an increase of 0.9% from 2022. The highest costs for business in The Contract Research Organizations industry in the US as a percentage of revenue are Wages (29.1%), Purchases (6.8%), and Rent & Utilities (3.4%, according to industry statistics of U.S. By leveraging the expertise and infrastructure of outsourcing partners, companies can optimize their operations, reduce financial risks, and accelerate the commercialization of their biologic products.

Biologics Outsourcing Market- Key Insights

  • As per the analysis shared by our research analyst, the global Biologics outsourcing market is estimated to grow annually at a CAGR of around XX% over the forecast period (2023-2030)
  • The Biologics outsourcing industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on product type segmentation, Antibody was the leading type in 2022
  • Based on Application segmentation, Therapeutics was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Biologics Outsourcing Market- Segmentation Analysis:

The Global Biologics Outsourcing Market is segmented on the basis of specificity, Type, Application, and Region.

The market is divided into five categories based on Product Type: Antibody, Recombinant, Protein, Vaccines, and Others. Antibody dominates the market. These are commonly outsourced types of biological products. Antibodies are proteins produced by the immune system in response to the presence of foreign substances, such as pathogens or abnormal cells. Outsourcing the development and manufacturing of antibodies can offer several advantages to biopharmaceutical companies.

The market is divided into three categories based on Application: Therapeutics, Diagnostics, and Research. Therapeutics dominate the market and are likely to maintain their dominance during the forecast period. Biologics Outsources are used for therapeutic purposes, often to treat complex diseases like cancer, autoimmune disorders, or genetic diseases. The biologics outsourcing market refers to the outsourcing of various processes related to the development, manufacturing, and commercialization of biologic drugs or therapeutics.

Biologics Outsourcing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate Biologics Outsourcing Market, due to increasing R&D spend of biopharma companies and escalating approvals and uptake of biosimilar. Biopharmaceutical companies in North America have been allocating significant resources to research and development activities. This focus on R&D allows them to develop innovative biologic drugs and therapies. Pharmaceutical Research and Manufacturers of America predicted that the U.S. biopharmaceutical industry has been the world leader in the development of new medicines, and PhRMA member companies continue to be at the forefront. The entire U.S. biopharmaceutical invested an estimated USD122 billion in R&D in 2020. Europe and Asia Pacific are expected to propel significant growth in Biologics Outsourcing Market, due to the Technological advancements in cell line engineering (gene editing tools) & cell line development technologies.

Biologics Outsourcing Market- Competitive Landscape:

Companies invest heavily in research and development to enhance their cell line development technologies, develop new products, and explore novel therapeutic applications. These players offer a wide range of services, including contract research, contract manufacturing, clinical trial services, and other support services for biopharmaceutical companies The Biologics outsourcing market is highly competitive, with several companies vying for market share. For instance, in 2023, Boehringer Ingelheim opens a USD386m German R&D plant. The Biologics Development Center (BDC) will develop antibodies and therapeutic proteins and manufacture substances for clinical trials, says Boehringer Ingelheim. The growth of biosimilar and the need for their development and manufacturing are also contributing to the demand for biologics outsourcing. Biosimilar developers often rely on outsourcing partners to leverage their expertise and infrastructure.

Recent Developments:

In April 2022, Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize the development, launch, and supply of better patient treatments across multiple modalities, nowadays announced the acquisition from Vaccine Manufacturing and Innovation Centre UK Limited (VMIC Ltd.) of a biologics development and manufacturing facility currently under construction near Oxford, U.K.

Key features of the study:

  • This proposed research study on Biologics outsourcing market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Biologics outsourcing market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Biologics outsourcing market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Biologics outsourcing market
  • Impact of COVID-19 on Biologics outsourcing market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Biologics outsourcing market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Biologics outsourcing market, we have also included competitive landscape and key innovator analysis for the Biologics outsourcing market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Biologics outsourcing market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Biologics outsourcing market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOLOGICS OUTSOURCING MARKET KEY PLAYERS

  • Boehringer Ingelheim
  • Catalent
  • GenScript
  • Innovent Biologics
  • Syngene
  • Shanghai Medicilon
  • GL Biochem Corporation
  • GVK Biosciences Private
  • Horizon Discovery Group
  • Selexis
  • Lonza
  • Abzena
  • Adimab

GLOBAL BIOLOGICS OUTSOURCING MARKET, BY PRODUCT TYPE

  • Antibody
  • Recombinant
  • Protein
  • Vaccines
  • Others

GLOBAL BIOLOGICS OUTSOURCING MARKET, BY APPLICATION

  • Therapeutics
  • Diagnostics
  • Research

GLOBAL BIOLOGICS OUTSOURCING MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

TABLE OF CONTENT

1. Biologics Outsourcing Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biologics Outsourcing Market Snippet by Product Type
    • 2.1.2. Biologics Outsourcing Market Snippet by Application
    • 2.1.3. Biologics Outsourcing Market Snippet by Country
    • 2.1.4. Biologics Outsourcing Market Snippet by Region
  • 2.2. Competitive Insights

3. Biologics Outsourcing Key Market Trends

  • 3.1. Biologics Outsourcing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biologics Outsourcing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biologics Outsourcing Market Opportunities
  • 3.4. Biologics Outsourcing Market Future Trends

4. Biologics Outsourcing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biologics Outsourcing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Biologics Outsourcing Market Landscape

  • 6.1. Biologics Outsourcing Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biologics Outsourcing Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
    • 7.1.2. Antibody
    • 7.1.3. Recombinant
    • 7.1.4. Protein
    • 7.1.5. Vaccines
    • 7.1.6. Others

8. Biologics Outsourcing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Therapeutics
    • 8.1.3. Diagnostics
    • 8.1.4. Research

9. Biologics Outsourcing Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Biologics Outsourcing Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Biologics Outsourcing Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Biologics Outsourcing Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Biologics Outsourcing Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Biologics Outsourcing Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Biologics Outsourcing Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Boehringer Ingelheim
    • 10.2.2. Catalent
    • 10.2.3. GenScript
    • 10.2.4. Innovent Biologics
    • 10.2.5. Syngene
    • 10.2.6. Shanghai Medicilon
    • 10.2.7. GL Biochem Corporation
    • 10.2.8. GVK Biosciences Private
    • 10.2.9. Horizon Discovery Group
    • 10.2.10. Selexis
    • 10.2.11. Lonza
    • 10.2.12. Abzena
    • 10.2.13. Adimab

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us